Whole-body MRI for the Detection of Metastasis

Overview

Develop and optimize protocols for whole body MRI for detection of metastases. Evaluate diagnostic accuracy through application of optimized protocols for screening of cancer patients.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: March 2018

Arms, Groups and Cohorts

  • Advanced breast cancer
    • Women with advanced breast cancer

Clinical Trial Outcome Measures

Primary Measures

  • Number of metastasis in skeleton
    • Time Frame: Baseline and after 6 months
    • Number of skeleton metastasis will be assessed at the regular clinical follow-up of breast cancer patients with metastatic disease

Participating in This Clinical Trial

Inclusion Criteria

  • Cancer patient Exclusion Criteria:

  • Poor general condition – Pacemaker or other MRI contraindications

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 95 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Norwegian University of Science and Technology
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Beathe Sitter, PhD, Principal Investigator, Norwegian University of Science and Technology

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.